These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24896627)

  • 1. Arguing the misconceptions in allergen-specific immunotherapy.
    Ridolo E; Montagni M; Bonzano L; Senna G; Incorvaia C
    Immunotherapy; 2014; 6(5):587-95. PubMed ID: 24896627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen immunotherapy: how to balance the different views from pulmonologists and allergists?
    Incorvaia C; Fuiano N; Frati F
    Immunotherapy; 2012 Aug; 4(8):853-7. PubMed ID: 22947011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical contraindications to allergen immunotherapy: an EAACI position paper.
    Pitsios C; Demoly P; Bilò MB; Gerth van Wijk R; Pfaar O; Sturm GJ; Rodriguez del Rio P; Tsoumani M; Gawlik R; Paraskevopoulos G; Ruëff F; Valovirta E; Papadopoulos NG; Calderón MA
    Allergy; 2015 Aug; 70(8):897-909. PubMed ID: 25913519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
    Ciprandi G; Tosca MA; Silvestri M
    Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy: the optimism and the issues.
    Pajno GB
    J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy (AIT) in asthma.
    Virchow JC
    Semin Immunol; 2019 Dec; 46():101334. PubMed ID: 31711771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical immunology review series: an approach to desensitization.
    Krishna MT; Huissoon AP
    Clin Exp Immunol; 2011 Feb; 163(2):131-46. PubMed ID: 21175592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' experience and opinion on contraindications to allergen immunotherapy: The CONSIT survey.
    Rodríguez Del Rio P; Pitsios C; Tsoumani M; Pfaar O; Paraskevopoulos G; Gawlik R; Valovirta E; Larenas-Linnemann D; Demoly P; Calderón MA
    Ann Allergy Asthma Immunol; 2017 May; 118(5):621-628.e1. PubMed ID: 28477792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors.
    Rank MA; Oslie CL; Krogman JL; Park MA; Li JT
    Allergy Asthma Proc; 2008; 29(4):400-5. PubMed ID: 18702889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient initiation and persistence with allergen immunotherapy.
    Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
    Bahceciler NN; Galip N; Cobanoglu N
    Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence.
    Passalacqua G
    Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):20-4. PubMed ID: 24362238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergen immunotherapy - a position paper of the German society for allergology and clinical immunology].
    Kleine-Tebbe J; Fuchs T; Klimek L; Kühr J; Lepp U; Niggemann B; Rakoski J; Renz H; Saloga J; Simon J
    Pneumologie; 2001 Sep; 55(9):438-44. PubMed ID: 11536068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen immunotherapy and standardization and stability of allergen extracts.
    Weber RW
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 2):1093-6. PubMed ID: 2600347
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-specific IgE and allergen immunotherapy in allergic children.
    Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
    Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.